Clinical Trials Browser

Phase 2 × Highly Endocrine Responsive Operable Breast Cancer × Tablets × Clear all

NCT03397537 2018-01-17

Neoadjuvant Endocrine Therapy in Breast Cancer

Phase 2 Completed

Highly Endocrine Responsive Operable Breast Cancer